helptariff

의료용품(ko) › Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses or in forms or(en)

其他麻醉劑

HS 300490韓國 → 臺灣

目的地關稅
0%
第一欄
營業稅
5%
通關難度

1概覽

  • 目的地關稅: 0% (第一欄, 30049010107) — 與韓國無優惠協定,適用基本/最惠國稅率。
  • 營業稅: 5%
  • 此號列涵蓋: 其他麻醉劑
  • 須留意的制度: Taiwan express low-value exemption and frequency capExpress consignments up to NT$2,000 are duty free, but a consignee exceeding six such entries in a half-year loses the exemption and moves to formal declaration.web.customs.gov.tw

重點

  • 小額免稅:同批貨物完稅價格新臺幣 2,000 元以下免徵關稅、營業稅與貨物稅;同一納稅義務人半年度內逾 6 次者列為頻繁進口,不再適用。
  • 營業稅 5%,由海關代徵;另有推廣貿易服務費 0.04%、貨物稅(限法定項目)與菸酒稅。
  • 委任報關業者非強制,納稅義務人可自行報關,但仍須透過關港貿單一窗口以電子方式申報。
  • 快遞貨物依完稅價格分為 X1(文件)、X2(2,000 元以下免稅)、X3(2,001 至 50,000 元應稅)、X4(逾 50,000 元,須以一般進口報單申報)。
  • 自中國大陸進口前,務必查詢貨品分類表「輸入規定」欄是否列有 MW0 或 MP1。

資料日期: 2026-07-29

2稅則分類

HS6 品名

  • ko기타
  • enOther anesthetics
  • zh_hant其他麻醉劑
  • zh_hans其他麻醉剂

臺灣 稅則號列

號列品名
30049010107醫藥製劑,含有硫美妥者(包括異構物、酯類、醚類及鹽類)Medicaments,containing thiamylal,5-allyl-5-(1-methylbutyl)-2-thiobarbiturates, including: Isomers, Esters, Ethers, Salts
30049010205醫藥製劑,含有愷他命及其異構物、酯類、醚類及鹽類者Medicaments, containing Ketamine , and its isomer, esters, ethers, salts
30049010303醫藥製劑,含有丙泊酚、依托咪酯,及其異構物、酯類、醚類及鹽類者Medicaments, containing Propofol , Etomidate, and their isomer, esters, ethers, salts
30049010900其他麻醉劑Other anesthetics
30049020007血液代用品與血漿代用品及基因重組製劑Substitutes of blood, substitutes of plasma and preparations of gennetic recombinants
30049030005營養與電解質液Nutrients and electrolytes
30049040003洗腎用清洗液,具有劑量或零售包裝式樣者Hemodialysis concentrate, put up in measured doses or in forms or packings for retail sale
30049050000磺胺藥Antibacterial, sulfa drugs
30049061007中藥酒劑Chinese medicine wine
30049069009其他中藥製劑Other chinese medicine preparations
30049071005抗癌藥Anti-cancer preparations
30049072004抗人類免疫缺乏病毒感染用藥Drugs for anti human immunodeficiency virus (HIV) infections
30049080004農藥中毒解毒劑Pesticide-poisoning cures
30049091001抗排斥醫藥製劑Immunosuppressive preparations
30049092000安瓿裝蒸餾水Water, distilled, in ampoules
30049099101抗過敏抗組織胺用藥Drugs for antihypersensitivity and antihistamine
30049099218醫藥製劑,含有西可巴比妥者Medicaments, containing secobarbital
30049099227醫藥製劑,含有異戊巴比妥者Medicaments, containing amobarbital
30049099316醫藥製劑,含有三唑他(三唑侖)者Medicaments, containing Triazolam
30049099325醫藥製劑,含有氟硝西泮者Medicaments, containing Flunitrazepam
30049099334醫藥製劑,含有氯甲西泮(甲基樂耐平)者Medicaments, containing Lormetazepam
30049099343醫藥製劑,含有氟地西泮(氟二氮平)者Medicaments, containing Fludiazepam
30049099352醫藥製劑,含有舒樂安定(伊疊唑侖)者Medicaments, containing Estazolam
30049099361醫藥製劑,含有阿普唑他(三氮二氮平)者Medicaments, containing Alprazolam
30049099370醫藥製劑,含有替馬西泮(甲羥氮平)者Medicaments, containing Temazepam
30049099389醫藥製劑,含有咪達唑他(咪氟唑侖)者Medicaments, containing Midazolam
30049099414醫藥製劑,含有特拉嗎竇者Medicaments, containing Tramadol
30049099423醫藥製劑,含有伯替唑他者Medicaments, containing Brotizolam
30049099432醫藥製劑,含有唑匹可隆者Medicaments, containing Zopiclone
30049099441玻璃體替代物Viscoelastic material for ophthalmic surgery
30049099450醫藥製劑,含有札來普隆者Medicaments, containing Zaleplon
30049099469醫藥製劑,含有佐沛眠者Medicaments, containing Zolpidem
30049099520醫藥製劑,含有瑞吩坦尼及其異構物、酯類、醚類及鹽類者Medicaments, containing Remifentanil, and its isomer, esters, ethers, salts
30049099539醫藥製劑,含有阿華吩坦尼及其異構物、酯類、醚類及鹽類者Medicaments, containing Alfentanyl , and its isomer, esters, ethers, salts
30049099548醫藥製劑,含有吩坦尼及其異構物、酯類、醚類及鹽類者Medicaments, containing Fentanyl , and its isomer, esters, ethers, salts
30049099557醫藥製劑,含有美沙冬及其異構物、酯類、醚類及鹽類者Medicaments, containing Methadone , and its isomer, esters, ethers, salts
30049099566醫藥製劑,含有潘他唑新及其異構物、酯類、醚類及鹽類者Medicaments, containing Pentazocine , and its isomer, esters, ethers, salts
30049099575醫藥製劑,含有蘇吩坦尼及其異構物、酯類、醚類及鹽類者Medicaments, containing Sufentanil , and its isomer, esters, ethers, salts
30049099584醫藥製劑,含有四氫大麻酚及其異構物、酯類、醚類及鹽類者Medicaments, containing Tetrahydrocannabinols, and its isomer, esters, ethers, salts
30049099593醫藥製劑,含有派醋甲酯及其異構物、酯類、醚類及鹽類者Medicaments, containing Methylphenidate , and its isomer, esters, ethers, salts
30049099619醫藥製劑,含有他噴他竇及其異構物、酯類、醚類及鹽類者Medicaments, containing Tapentadol, and its isomers, esters, ethers, salts
30049099628醫藥製劑,含有戊巴比妥(不含異戊巴比妥)及其異構物、酯類、醚類及鹽類者Medicaments, containing Pentobarbital(excluding amobarbital), and its isomer, esters, ethers, salts
30049099637醫藥製劑,含有硝甲西泮(硝甲氮平)及其異構物、酯類、醚類及鹽類者Medicaments, containing Nimetazepam , and its isomer, esters, ethers, salts
30049099646醫藥製劑,含有巴比妥及其異構物、酯類、醚類及鹽類者Medicaments, containing Barbital , and its isomer, esters, ethers, salts
30049099655醫藥製劑,含有溴西泮(溴氮平)及其異構物、酯類、醚類及鹽類者Medicaments, containing Bromazepam , and its isomer, esters, ethers, salts
30049099664醫藥製劑,含有勞拉西泮(樂耐平)及其異構物、酯類、醚類及鹽類者Medicaments, containing Lorazepam , and its isomer, esters, ethers, salts
30049099673醫藥製劑,含有美達西泮(美達氮平)及其異構物、酯類、醚類及鹽類者Medicaments, containing Medazepam , and its isomer, esters, ethers, salts
30049099682醫藥製劑,含有甲丙氨酯(美普巴邁)及其異構物、酯類、醚類及鹽類者Medicaments, containing Meprobamate , and its isomer, esters, ethers, salts
30049099691醫藥製劑,含有硝西泮(耐妥眠)及其異構物、酯類、醚類及鹽類者Medicaments, containing Nitrazepam , and its isomer, esters, ethers, salts
30049099717醫藥製劑,含有去甲西泮(原氮平)及其異構物、酯類、醚類及鹽類者Medicaments, containing Nordazepam , and its isomer, esters, ethers, salts
30049099726醫藥製劑,含有去甲羥安定(歐沙氮平、去甲羥氮平)及其異構物、酯類、醚類及鹽類者Medicaments, containing Oxazepam , and its isomer, esters, ethers, salts
30049099735醫藥製劑,含有噁唑他(㗁甲唑侖)及其異構物、酯類、醚類及鹽類者Medicaments, containing Oxazolam , and its isomer, esters, ethers, salts
30049099744醫藥製劑,含有匹嗎啉(苯㗁唑啉)及其異構物、酯類、醚類及鹽類者Medicaments, containing Pemoline , and its isomer, esters, ethers, salts
30049099753醫藥製劑,含有氯巴占(甲酮氮平)及其異構物、酯類、醚類及鹽類者Medicaments, containing clobazam , and its isomer, esters, ethers, salts
30049099762醫藥製劑,含有氯硝西泮(可那氮平、氯硝氮平)及其異構物、酯類、醚類及鹽類者Medicaments, containing Clonazepam , and its isomer, esters, ethers, salts
30049099771醫藥製劑,含有氯拉䓬酸(氯氮平酸鹽)及其異構物、酯類、醚類及鹽類者Medicaments, containing Clorazepate , and its isomer, esters, ethers, salts
30049099780醫藥製劑,含有氯噁唑他(氯㗁唑侖)及其異構物、酯類、醚類及鹽類者Medicaments, containing Cloxazolam , and its isomer, esters, ethers, salts
30049099799醫藥製劑,含有安定(二氮平)及其異構物、酯類、醚類及鹽類者Medicaments, containing Diazepam , and its isomer, esters, ethers, salts
30049099815醫藥製劑,含有氟安定(氟路洛)及其異構物、酯類、醚類及鹽類者Medicaments, containing Flurazepam , and its isomer, esters, ethers, salts
30049099824醫藥製劑,含有普拉西泮(環丙氮平)及其異構物、酯類、醚類及鹽類者Medicaments, containing Prazepam , and its isomer, esters, ethers, salts
30049099833醫藥製劑,含有莫待芬寧及其異構物、酯類、醚類及鹽類者Medicaments, containing Modafinil , and its isomer, esters, ethers, salts
30049099842醫藥製劑,含有美妥芬諾及其異構物、酯類、醚類及鹽類者Medicaments, containing Butorphanol , and its isomer, esters, ethers, salts
30049099851醫藥製劑,含有氯苄雷司及其異構物、酯類、醚類及鹽類者Medicaments, containing Clobenzorex , and its isomer, esters, ethers, salts
30049099860醫藥製劑,含有離胺右旋安非他命及其異構物、酯類、醚類及鹽類者Medicaments, containing Lisdexamphetamine , and its isomer, esters, ethers, salts
30049099904其他醫藥製劑〈不包括第3002、3005或3006節所列者〉包含經混合或未混合產品供治療或預防疾病用,具有劑量(包括經皮給藥形態者)或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale
韓國 出口端號列(參考)
  • 3004901000항결핵제ㆍ구충제 및 항암제
  • 3004909100아스피린제제
  • 3004909200항히스타민제제
  • 3004909300녹용제제
  • 3004909400인삼제제
  • 3004909500로얄제리 제제
  • 3004909900기타

不是你的商品?重新搜尋

資料日期: 2026-07-29

3關稅與稅金

與韓國無優惠協定,適用基本/最惠國稅率。

號列品名第一欄第二欄第三欄
30049010107醫藥製劑,含有硫美妥者(包括異構物、酯類、醚類及鹽類)0%0%0%
30049010205醫藥製劑,含有愷他命及其異構物、酯類、醚類及鹽類者0%0%0%
30049010303醫藥製劑,含有丙泊酚、依托咪酯,及其異構物、酯類、醚類及鹽類者0%0%0%
30049010900其他麻醉劑0%0%0%
30049020007血液代用品與血漿代用品及基因重組製劑0%0%0%
30049030005營養與電解質液0%0%10%
30049040003洗腎用清洗液,具有劑量或零售包裝式樣者0%0%10%
30049050000磺胺藥0%0%20%
30049061007中藥酒劑20%0%50%
30049069009其他中藥製劑0%0%12.5%
30049071005抗癌藥0%0%0%
30049072004抗人類免疫缺乏病毒感染用藥0%0%10%
30049080004農藥中毒解毒劑0%0%0%
30049091001抗排斥醫藥製劑0%0%10%
30049092000安瓿裝蒸餾水0%0%10%
30049099101抗過敏抗組織胺用藥0%0%10%
30049099218醫藥製劑,含有西可巴比妥者0%0%10%
30049099227醫藥製劑,含有異戊巴比妥者0%0%10%
30049099316醫藥製劑,含有三唑他(三唑侖)者0%0%10%
30049099325醫藥製劑,含有氟硝西泮者0%0%10%
30049099334醫藥製劑,含有氯甲西泮(甲基樂耐平)者0%0%10%
30049099343醫藥製劑,含有氟地西泮(氟二氮平)者0%0%10%
30049099352醫藥製劑,含有舒樂安定(伊疊唑侖)者0%0%10%
30049099361醫藥製劑,含有阿普唑他(三氮二氮平)者0%0%10%
30049099370醫藥製劑,含有替馬西泮(甲羥氮平)者0%0%10%
30049099389醫藥製劑,含有咪達唑他(咪氟唑侖)者0%0%10%
30049099414醫藥製劑,含有特拉嗎竇者0%0%10%
30049099423醫藥製劑,含有伯替唑他者0%0%10%
30049099432醫藥製劑,含有唑匹可隆者0%0%10%
30049099441玻璃體替代物0%0%10%
30049099450醫藥製劑,含有札來普隆者0%0%10%
30049099469醫藥製劑,含有佐沛眠者0%0%10%
30049099520醫藥製劑,含有瑞吩坦尼及其異構物、酯類、醚類及鹽類者0%0%10%
30049099539醫藥製劑,含有阿華吩坦尼及其異構物、酯類、醚類及鹽類者0%0%10%
30049099548醫藥製劑,含有吩坦尼及其異構物、酯類、醚類及鹽類者0%0%10%
30049099557醫藥製劑,含有美沙冬及其異構物、酯類、醚類及鹽類者0%0%10%
30049099566醫藥製劑,含有潘他唑新及其異構物、酯類、醚類及鹽類者0%0%10%
30049099575醫藥製劑,含有蘇吩坦尼及其異構物、酯類、醚類及鹽類者0%0%10%
30049099584醫藥製劑,含有四氫大麻酚及其異構物、酯類、醚類及鹽類者0%0%10%
30049099593醫藥製劑,含有派醋甲酯及其異構物、酯類、醚類及鹽類者0%0%10%
30049099619醫藥製劑,含有他噴他竇及其異構物、酯類、醚類及鹽類者0%0%10%
30049099628醫藥製劑,含有戊巴比妥(不含異戊巴比妥)及其異構物、酯類、醚類及鹽類者0%0%10%
30049099637醫藥製劑,含有硝甲西泮(硝甲氮平)及其異構物、酯類、醚類及鹽類者0%0%10%
30049099646醫藥製劑,含有巴比妥及其異構物、酯類、醚類及鹽類者0%0%10%
30049099655醫藥製劑,含有溴西泮(溴氮平)及其異構物、酯類、醚類及鹽類者0%0%10%
30049099664醫藥製劑,含有勞拉西泮(樂耐平)及其異構物、酯類、醚類及鹽類者0%0%10%
30049099673醫藥製劑,含有美達西泮(美達氮平)及其異構物、酯類、醚類及鹽類者0%0%10%
30049099682醫藥製劑,含有甲丙氨酯(美普巴邁)及其異構物、酯類、醚類及鹽類者0%0%10%
30049099691醫藥製劑,含有硝西泮(耐妥眠)及其異構物、酯類、醚類及鹽類者0%0%10%
30049099717醫藥製劑,含有去甲西泮(原氮平)及其異構物、酯類、醚類及鹽類者0%0%10%
30049099726醫藥製劑,含有去甲羥安定(歐沙氮平、去甲羥氮平)及其異構物、酯類、醚類及鹽類者0%0%10%
30049099735醫藥製劑,含有噁唑他(㗁甲唑侖)及其異構物、酯類、醚類及鹽類者0%0%10%
30049099744醫藥製劑,含有匹嗎啉(苯㗁唑啉)及其異構物、酯類、醚類及鹽類者0%0%10%
30049099753醫藥製劑,含有氯巴占(甲酮氮平)及其異構物、酯類、醚類及鹽類者0%0%10%
30049099762醫藥製劑,含有氯硝西泮(可那氮平、氯硝氮平)及其異構物、酯類、醚類及鹽類者0%0%10%
30049099771醫藥製劑,含有氯拉䓬酸(氯氮平酸鹽)及其異構物、酯類、醚類及鹽類者0%0%10%
30049099780醫藥製劑,含有氯噁唑他(氯㗁唑侖)及其異構物、酯類、醚類及鹽類者0%0%10%
30049099799醫藥製劑,含有安定(二氮平)及其異構物、酯類、醚類及鹽類者0%0%10%
30049099815醫藥製劑,含有氟安定(氟路洛)及其異構物、酯類、醚類及鹽類者0%0%10%
30049099824醫藥製劑,含有普拉西泮(環丙氮平)及其異構物、酯類、醚類及鹽類者0%0%10%
30049099833醫藥製劑,含有莫待芬寧及其異構物、酯類、醚類及鹽類者0%0%10%
30049099842醫藥製劑,含有美妥芬諾及其異構物、酯類、醚類及鹽類者0%0%10%
30049099851醫藥製劑,含有氯苄雷司及其異構物、酯類、醚類及鹽類者0%0%10%
30049099860醫藥製劑,含有離胺右旋安非他命及其異構物、酯類、醚類及鹽類者0%0%10%
30049099904其他醫藥製劑〈不包括第3002、3005或3006節所列者〉包含經混合或未混合產品供治療或預防疾病用,具有劑量(包括經皮給藥形態者)或零售包裝式樣者0%0%10%
  • · 營業稅=(完稅價格+進口稅+貨物稅或菸酒稅+菸品健康福利捐)× 5%,依營業稅法第 41 條由海關代徵。
  • · 推廣貿易服務費:按完稅價格 0.04% 計收(設有最低門檻)。
  • · 貨物稅:僅對貨物稅條例所列項目課徵,例如電器、車輛、油氣、水泥、飲料、平板玻璃與橡膠輪胎;計算基礎為完稅價格加進口稅。
  • · 菸酒稅:捲菸每千支新臺幣 1,590 元、啤酒每公升 26 元、蒸餾酒每公升每度 2.5 元等;菸品另加健康福利捐每千支 1,000 元。
  • · 特種貨物及勞務稅:對逾一定金額的小客車、飛機、遊艇及高價貨物課徵 10%。

稅金概算

採用稅率
0%
完稅價格
關稅
營業稅
預估總額

此為概算。實際金額會因完稅價格核定、稅則歸列與原產地認定而不同。

資料日期: 2026-07-29

4輸入規定

  • 503進口人用藥品(包括製劑、原料藥、助診藥類及人用生物製劑):應檢附(一)藥商許可執照影本及衛生福利部核發之(輸入)藥品許可證影本,或(二)衛生福利部核發之同意文件。

    Importation of drugs (including pharmaceutical products, active pharmaceutical ingredients, diagnostics and biological products) for human use requires either of the following: (1) a photocopy of the drug (import) license issued by the Ministry of Health and Welfare together with a photocopy of the license of the pharmaceutical firm; or (2) an approval issued by the Ministry of Health and Welfa…

  • 504一、進口人用醫療器材應依下列規定辦理:(一)應檢附衛生福利部核發之醫療器材許可證影本或同意文件,並應申報填列醫療器材許可證號碼(十四碼)。(二)如屬危險性醫療儀器,除應檢附衛生福利部核發之醫療器材許可證影本,及申報填列醫療器材許可證號碼(十四碼)外,並須檢附衛生福利部核准醫療機構購置之同意文件。二、非供人用者免依上述規定辦理。

    1. Importation of medical devices for human use must be handled according to the following regulations: (1) A photocopy of the medical devices pre-marketing license or an approval document issued by the Ministry of Health and Welfare should be submitted. In addition, the number of the pre-marketing license (consisting of 14 letters and digits) must be declared and listed in the import declaration…

  • 505進口中藥藥品(藥品許可證處方內容以中文標示者)應檢附(一)藥商許可執照影本及衛生福利部核發之(輸入)藥品許可證影本,或(二)衛生福利部中醫藥司核發之同意文件。

    Importation of Chinese medicines (with the content of the formula of the drug written in Chinese on the import license) requires either of the following: (1) a photocopy of the drug (import) license issued by the Ministry of Health and Welfare together with a photocopy of the license of the pharmaceutical firm; or (2) an approval issued by the Department of Chinese Medicine and Pharmacy, Ministry…

  • 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。

    For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs

  • 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。

    For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs

  • 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。

    For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs

  • 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。

    For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs

  • 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。

    For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs

  • 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。

    For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs

  • 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。

    For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs

  • 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。

    For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs

  • 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。

    For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs

  • 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。

    For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs

  • 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。

    For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs

  • 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。

    For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs

  • 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。

    For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs

  • 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。

    For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs

  • 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。

    For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs

  • 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。

    For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs

  • 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。

    For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs

  • 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。

    For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs

  • 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。

    For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs

  • 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。

    For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs

  • 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。

    For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs

  • 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。

    For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs

  • 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。

    For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs

  • 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。

    For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs

  • 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。

    For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs

  • 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。

    For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs

  • 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。

    For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs

  • 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。

    For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs

  • 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。

    For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs

  • 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。

    For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs

  • 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。

    For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs

  • 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。

    For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs

  • 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。

    For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs

  • 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。

    For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs

  • 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。

    For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs

  • 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。

    For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs

  • 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。

    For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs

  • 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。

    For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs

  • 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。

    For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs

  • 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。

    For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs

  • 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。

    For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs

  • 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。

    For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs

  • 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。

    For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs

  • 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。

    For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs

  • 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。

    For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs

  • 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。

    For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs

  • 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。

    For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs

  • 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。

    For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs

  • 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。

    For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs

  • 522進口管制藥品(包括人用、動物用麻醉藥品、影響精神藥品及其原料)應檢附衛生福利部食品藥物管理署核發之同意文件(輸入憑照或輸入同意書);該同意文件第二聯於通關時經海關核驗簽署後,由進口人交還食品藥物管理署。

    For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an approval issued by Food and Drug Administration , Ministry of Health and Welfare is required. Importer must return one copy of the above mentioned approval to issuing authority after clearance and endorsement by customs

  • 802(一)進口人用藥品,應依503規定辦理(二)進口動物用藥品,應依406規定辦理。(三)進口非屬上述項目者,應註明「本貨品非屬人用藥品、動物用藥品」字樣,免依上述規定辦理。

    (1) Importation of medicines for human use is governed by the regulation of"503".(2) Importation of veterinary medicines is governed by the regulation of "406".(3)Importation of commodity not belong the aforesaid items shall be exempted from the aforesaid regulations, but a clear indication that the commodity is "not to be used as human use and veterinary medicines" is required.

  • 802(一)進口人用藥品,應依503規定辦理(二)進口動物用藥品,應依406規定辦理。(三)進口非屬上述項目者,應註明「本貨品非屬人用藥品、動物用藥品」字樣,免依上述規定辦理。

    (1) Importation of medicines for human use is governed by the regulation of"503".(2) Importation of veterinary medicines is governed by the regulation of "406".(3)Importation of commodity not belong the aforesaid items shall be exempted from the aforesaid regulations, but a clear indication that the commodity is "not to be used as human use and veterinary medicines" is required.

  • 802(一)進口人用藥品,應依503規定辦理(二)進口動物用藥品,應依406規定辦理。(三)進口非屬上述項目者,應註明「本貨品非屬人用藥品、動物用藥品」字樣,免依上述規定辦理。

    (1) Importation of medicines for human use is governed by the regulation of"503".(2) Importation of veterinary medicines is governed by the regulation of "406".(3)Importation of commodity not belong the aforesaid items shall be exempted from the aforesaid regulations, but a clear indication that the commodity is "not to be used as human use and veterinary medicines" is required.

  • 802(一)進口人用藥品,應依503規定辦理(二)進口動物用藥品,應依406規定辦理。(三)進口非屬上述項目者,應註明「本貨品非屬人用藥品、動物用藥品」字樣,免依上述規定辦理。

    (1) Importation of medicines for human use is governed by the regulation of"503".(2) Importation of veterinary medicines is governed by the regulation of "406".(3)Importation of commodity not belong the aforesaid items shall be exempted from the aforesaid regulations, but a clear indication that the commodity is "not to be used as human use and veterinary medicines" is required.

  • 802(一)進口人用藥品,應依503規定辦理(二)進口動物用藥品,應依406規定辦理。(三)進口非屬上述項目者,應註明「本貨品非屬人用藥品、動物用藥品」字樣,免依上述規定辦理。

    (1) Importation of medicines for human use is governed by the regulation of"503".(2) Importation of veterinary medicines is governed by the regulation of "406".(3)Importation of commodity not belong the aforesaid items shall be exempted from the aforesaid regulations, but a clear indication that the commodity is "not to be used as human use and veterinary medicines" is required.

  • 802(一)進口人用藥品,應依503規定辦理(二)進口動物用藥品,應依406規定辦理。(三)進口非屬上述項目者,應註明「本貨品非屬人用藥品、動物用藥品」字樣,免依上述規定辦理。

    (1) Importation of medicines for human use is governed by the regulation of"503".(2) Importation of veterinary medicines is governed by the regulation of "406".(3)Importation of commodity not belong the aforesaid items shall be exempted from the aforesaid regulations, but a clear indication that the commodity is "not to be used as human use and veterinary medicines" is required.

  • 802(一)進口人用藥品,應依503規定辦理(二)進口動物用藥品,應依406規定辦理。(三)進口非屬上述項目者,應註明「本貨品非屬人用藥品、動物用藥品」字樣,免依上述規定辦理。

    (1) Importation of medicines for human use is governed by the regulation of"503".(2) Importation of veterinary medicines is governed by the regulation of "406".(3)Importation of commodity not belong the aforesaid items shall be exempted from the aforesaid regulations, but a clear indication that the commodity is "not to be used as human use and veterinary medicines" is required.

  • 804(一)進口人用藥品,應依503規定辦理(二)進口人用醫療器材,應依504規定辦理。(三)進口動物用藥品,應依406規定辦理。(四)進口非屬上述項目者,應註明「本貨品非屬人用藥品、人用醫療器材、動物用藥品」字樣,免依上述規定辦理。

    (1) Importation of medicines for human use is governed by the regulation of"503".(2) Importation of medical devices for human use is governed by the regulation of"504" (3)Importation of veterinary medicines is governed by the regulation of "406".(4)Importation of commodity not belong the aforesaid items shall be exempted from the aforesaid regulations, but a clear indication that the commodity is…

  • 804(一)進口人用藥品,應依503規定辦理(二)進口人用醫療器材,應依504規定辦理。(三)進口動物用藥品,應依406規定辦理。(四)進口非屬上述項目者,應註明「本貨品非屬人用藥品、人用醫療器材、動物用藥品」字樣,免依上述規定辦理。

    (1) Importation of medicines for human use is governed by the regulation of"503".(2) Importation of medical devices for human use is governed by the regulation of"504" (3)Importation of veterinary medicines is governed by the regulation of "406".(4)Importation of commodity not belong the aforesaid items shall be exempted from the aforesaid regulations, but a clear indication that the commodity is…

  • 804(一)進口人用藥品,應依503規定辦理(二)進口人用醫療器材,應依504規定辦理。(三)進口動物用藥品,應依406規定辦理。(四)進口非屬上述項目者,應註明「本貨品非屬人用藥品、人用醫療器材、動物用藥品」字樣,免依上述規定辦理。

    (1) Importation of medicines for human use is governed by the regulation of"503".(2) Importation of medical devices for human use is governed by the regulation of"504" (3)Importation of veterinary medicines is governed by the regulation of "406".(4)Importation of commodity not belong the aforesaid items shall be exempted from the aforesaid regulations, but a clear indication that the commodity is…

  • 814(一)進口人用中藥藥品,應依505規定辦理。(二)進口動物用中藥藥品,應依406規定辦理。(三)進口本項貨品未取得上開主管機關輸入許可文件者,不准進口。

    (1) Importation of traditional chinese drugs for human use is governed by the regulation of "505". (2) Importation of veterinary chinese medicines is governed by the regulation of "406".(3) For importing good under this item without import approval document from the competent authority, is not allowed to be imported.

  • MP1(一)大陸物品有條件准許輸入,應符合「大陸物品有條件准許輸入項目、輸入管理法規彙總表」之規定。(二)「大陸物品有條件准許輸入項目、輸入管理法規彙總表」內列有特別規定「MXX」代號者,應向國際貿易署辦理輸入許可證;未列有特別規定「MXX」代號者,依一般簽證規定辦理。

    (1) Importation of Mainland China products in this category is conditionally permitted. The importation should conform to the regulations of "Consolidated List of Conditional Import Items of Mainland China Origin and Regulations Governing Import of Mainland China Origin Commodities".(2) Importation of items on the "Consolidated List of Conditional Import Items of Mainland China Origin and Regulat…

  • MW0大陸物品不准輸入。

    Importation of Mainland China products is prohibited.

  • MW0大陸物品不准輸入。

    Importation of Mainland China products is prohibited.

  • MW0大陸物品不准輸入。

    Importation of Mainland China products is prohibited.

  • MW0大陸物品不准輸入。

    Importation of Mainland China products is prohibited.

  • MW0大陸物品不准輸入。

    Importation of Mainland China products is prohibited.

  • MW0大陸物品不准輸入。

    Importation of Mainland China products is prohibited.

  • MW0大陸物品不准輸入。

    Importation of Mainland China products is prohibited.

  • MW0大陸物品不准輸入。

    Importation of Mainland China products is prohibited.

  • MW0大陸物品不准輸入。

    Importation of Mainland China products is prohibited.

相關機關

  • 財政部關務署進口通關、稅則分類、關稅核估與代徵營業稅、貨物稅web.customs.gov.tw
  • 關港貿單一窗口進出口報單、輸入規定查詢與稅費繳納的電子平臺portal.sw.nat.gov.tw
  • 經濟部國際貿易署貨品輸出入規定、輸入許可證、大陸物品輸入管理(MW0/MP1)trade.gov.tw
  • 經濟部標準檢驗局(BSMI)應施檢驗商品的報驗、驗證與商品安全標示bsmi.gov.tw
  • 衛生福利部食品藥物管理署(TFDA)輸入食品邊境查驗、化粧品產品登錄與產品資訊檔案fda.gov.tw
  • 農業部動植物防疫檢疫署動植物及其產品的輸入檢疫aphia.gov.tw

資料日期: 2026-08-27

5文件

韓國 出口文件

  • 出口申報書(수출신고서)
    核發單位:
    出口人或關稅士,於 UNI-PASS 申報
    時點:
    裝載前

    填報 HS 號列、數量、金額、貿易條件、原產地與是否申請退稅。

    官方頁面
  • 出口申報受理證(수출신고필증)
    核發單位:
    海關
    時點:
    出口申報受理時核發

    用於零稅率申報、關稅退稅、貿易金融與保險。

    官方頁面
  • 商業發票
    核發單位:
    出口人
    時點:
    備妥裝運文件時

    輸入國海關據以核估完稅價格,品名、數量、單價、貿易條件與原產地須正確。

    官方頁面
  • 裝箱單
    核發單位:
    出口人
    時點:
    備妥裝運文件時

    逐箱內容、重量、材積與嘜頭。

    官方頁面
  • 提單(B/L)或空運提單(AWB)
    核發單位:
    運送人或承攬業者
    時點:
    裝載後簽發

    用於押匯或其他付款方式,並供買方提貨。

    官方頁面
  • FTA 原產地證明書
    核發單位:
    海關、大韓商工會議所(機關簽發)或出口人(自行簽發)
    時點:
    買方主張優惠前

    美韓 FTA 採自行簽發、無固定格式;韓中 FTA 採機關簽發;RCEP 依協定所定方式。與臺灣之間並無協定。

    官方頁面
  • 戰略物資判定書或出口許可證
    核發單位:
    戰略物資管理院(KOSTI)、產業通商資源部
    時點:
    該項貨物出口前

    兩用物項須經自行判定或專業判定,必要時取得出口許可。

    官方頁面
  • 出口用衛生或檢疫證明
    核發單位:
    食品醫藥品安全處、農林畜產檢疫本部等
    時點:
    輸入國要求時

    例如出口食品的衛生證明、植物檢疫證明、動物檢疫證明。輸往中國大陸的食品另須辦理海關總署(GACC)境外生產企業註冊。

    官方頁面
  • 關稅退稅申請文件
    核發單位:
    出口人
    時點:
    出口履行後

    依定額退稅或個別退稅方式,需檢附進口申報受理證、基礎原材料納稅證明等。

    官方頁面

臺灣 進口文件

  • 進口報單
    核發單位:
    報關業者或進口人,經關港貿單一窗口傳輸
    時點:
    自運輸工具進口日之翌日起 15 日內

    低價快遞貨物得改以簡易申報單(X1 至 X3)申報;涉及輸入規定、退稅、配額、特別關稅或特種貨物稅者,須以一般進口報單申報。

    官方頁面
  • 小提單(提貨單,D/O)
    核發單位:
    運送人或承攬業者
    時點:
    貨物抵達後換領

    憑以自貨櫃集散站或倉庫提領貨物。

    官方頁面
  • 商業發票
    核發單位:
    出口人
    時點:
    報關時

    核估完稅價格的主要依據,應載明品名、數量、單價、貿易條件與原產地。

    官方頁面
  • 裝箱單
    核發單位:
    出口人
    時點:
    報關時

    查驗(C3)時作為核對資料。

    官方頁面
  • 提單(B/L)或空運提單(AWB)
    核發單位:
    運送人
    時點:
    裝運時簽發

    與艙單核對,並作為換領小提單的依據。

    官方頁面
  • 產地證明書
    核發單位:
    出口國簽發機構
    時點:
    適用優惠稅率或輸入規定要求時

    自中國大陸輸入早收清單貨品欲適用 ECFA 優惠者,須檢附 ECFA 原產地證明書。

    官方頁面
  • 輸入許可證
    核發單位:
    經濟部國際貿易署或其他主管機關
    時點:
    貨品分類表「輸入規定」欄有相應代號時

    無代號者多為免證進口;MW0、MP1 等代號涉及大陸物品的輸入管理。

    官方頁面
  • 委任書
    核發單位:
    進口人(納稅義務人)
    時點:
    委任報關業者前

    報關業者據以代辦報關、繳稅與提領。

    官方頁面
  • 檢驗與查驗文件
    核發單位:
    經濟部標準檢驗局(BSMI)、衛生福利部食品藥物管理署(TFDA)
    時點:
    報關同時或報關前

    應施檢驗商品的報驗合格證明;輸入食品的查驗申請;化粧品的產品登錄與產品資訊檔案(PIF)。

    官方頁面

6流程

  1. 預報貨物資訊與進儲運送人傳輸艙單,貨物卸船後進儲貨櫃集散站、碼頭或保稅倉庫。
  2. 換領小提單與備妥文件向運送人或承攬業者換領小提單,備妥發票、裝箱單、產地證明與必要的輸入許可證。
  3. 遞送進口報單由報關業者或進口人經關港貿單一窗口遞送進口報單,申報期限為自運輸工具進口日之翌日起 15 日內。
  4. 通關方式篩選系統篩選為 C1(免審免驗)、C2(文件審核)或 C3(貨物查驗,分人工查驗 C3M 與儀器查驗 C3X)。屬應施檢驗或查驗商品者,須先取得主管機關結果。
  5. 繳納稅費繳納關稅、營業稅、貨物稅(如有)與推廣貿易服務費,可線上繳納,亦可依規定申請先放後稅。
  6. 放行與提領取得放行通知後自集散站提領貨物。事後仍有更正、退稅與海關事後稽核等程序。
  1. 艙單與進儲航空公司傳輸艙單,貨物進儲航空貨物集散站。
  2. 備妥文件與遞送報單備妥文件後經關港貿單一窗口遞送進口報單,同樣適用 15 日申報期限。
  3. 通關方式與查驗依 C1/C2/C3 分流;屬 BSMI 或 TFDA 管理商品者,須完成報驗或查驗程序。
  4. 繳稅繳納關稅、營業稅與相關規費。
  5. 放行提貨自航空貨物集散站提領貨物。
  1. 快遞貨物分類依完稅價格分為 X1(進口快遞文件)、X2(2,000 元以下低價免稅)、X3(2,001 至 50,000 元低價應稅)與 X4(逾 50,000 元高價貨物)。
  2. 簡易申報或一般報單X1 至 X3 得以簡易申報單申報;X4 及涉及輸入規定、退稅、配額、特別關稅或特種貨物稅者,須以一般進口報單申報。
  3. 免稅與頻繁進口判斷完稅價格 2,000 元以下者免稅,但同一納稅義務人半年度內逾 6 次者列為頻繁進口,其後不再適用免稅。菸、酒與關稅配額農產品不適用。
  4. 繳稅應稅者由快遞業者代為繳納後向收貨人收取,或由收貨人自行繳納。
  5. 應施檢驗商品跨境網購的電器等應施檢驗商品,仍須依規定報驗或申請免驗,未符規定者不予放行並可能受罰。
  1. 入境申報旅客攜帶行李物品入境時,應稅或應申報物品走紅線檯,並填具申報單。
  2. 免稅額度成年旅客自用行李物品完稅價格總值在新臺幣 20,000 元以下者免稅,酒類與菸品另有數量限制。
  3. 商業性貨物非自用的商業性貨物即使隨身攜帶,仍須依一般進口程序報關,並符合輸入規定與檢驗要求。
  4. 繳稅逾免稅額度部分於入境時由海關核估課稅並當場繳納。
顯示 韓國 出口端流程
  1. 事前檢視確定 HS 號列並判定是否屬戰略物資。輸入國要求的登錄或註冊(例如輸往中國大陸食品的 GACC 註冊、輸往美國化粧品的 MoCRA 登錄)須於裝運前完成。
  2. 出口申報出口人自行或委任關稅士於 UNI-PASS 遞送出口申報書。擬申請退稅者,於申報階段一併填報相關欄位。
  3. 審核、查驗與受理海關審核文件,必要時查驗貨物,受理申報並核發出口申報受理證。
  4. 進場與裝船將貨櫃送交貨櫃場或集散站並裝船。需跨關區移動時採保稅運送。
  5. 裝載期限管理應於受理日起 30 日內完成裝載;預期延誤者,申請延長裝載期限。
  6. 裝運文件與後續取得提單辦理收款,並辦理加值稅零稅率申報與關稅退稅申請。

7難度

建議委任報關業者

分數: 0.87

這是依公開資料計算的訊號,並非諮詢意見。

判定理由

  • regime[TFDA] Medicines need a pharmaceutical-firm licence and a per-product marketing licence; even personal-use import is quantity-capped.(en)fda.gov.tw2026-09-07
  • requirement6 destination import requirement(s) found: For importation of controlled drugs (including narcotics dru, (1) Importation of medicines for human use is governed by th, Importation of Chinese medicines (with the content of the fo(en)portal.sw.nat.gov.tw2026-09-07
  • ambiguityClassification is contested — rulings for this HS6 scatter across several subheadings and are often decided against neighbouring codes(en)web.customs.gov.tw2026-09-07

組成

進口規定0.89For importation of controlled drugs (including narcotics drugs and psychotropic substances for human use or veterinary medicines as well as active pharmaceutical ingredient), an ap portal.sw.nat.gov.tw(1) Importation of medicines for human use is governed by the regulation of"503".(2) Importation of veterinary medicines is governed by the regulation of "406".(3)Importation of co portal.sw.nat.gov.twImportation of Chinese medicines (with the content of the formula of the drug written in Chinese on the import license) requires either of the following: (1) a photocopy of the dru portal.sw.nat.gov.tw
歸列模糊度0.56TW 결정례 17건 · 하위 세번 2종으로 분산 web.customs.gov.twUS CROSS 1057건 중 복수 세번 결정 비율 21% · 같은 사건에서 함께 검토된 다른 HS6 66개 rulings.cbp.gov
管制制度1.00藥事法 — 藥商許可執照 + 藥品許可證 fda.gov.tw
韓國 出口端備註: Korea’s customs-verified requirement list is import-side only; export controls (Foreign Trade Act, strategic items) must be checked separately. unipass.customs.go.kr

資料日期: 2026-09-07

8案例

顯示其他國家案例 (30)

來源: 財政部 — 海外網購雖容易 頻繁進口要留意 · 財政部關務署 — 海關如何課徵進口貨物營業稅? · 財政部關務署 — 進口貨物應繳之稅費有那些? · 財政部關務署 — 大陸物品准許輸入項目為何? · 財政部關務署臺北關 — 進口快遞貨物簡易申報應注意及配合事項 · 財政部主管法規共用系統 — 空運快遞貨物簡易申報通關作業規定 · 經濟部國際貿易署 — 大陸物品輸入特別規定查詢 · 衛生福利部食品藥物管理署 — 化粧品產品登錄專區 · 韓國關稅廳 — 出口通關 · 韓國關稅廳 UNI-PASS · 韓國關稅廳 FTA 入口網 · 韓國戰略物資管理院 Yestrade · 韓國國家法令資訊中心 — 關稅法、對外貿易法 · 韓國農林畜產檢疫本部

身分: 承攬業者 — 會改變頁面強調的區塊